Traditional and Novel Dietary Interventions for Preventing Progression of Chronic Kidney Disease

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Treatment of chronic kidney disease (CKD) and its complications remain largely unresolved. Currently used treatments include blood pressure control and the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which can slow down the progression of CKD but are unable to halt or reverse it. Dietary protein restriction represents an additional therapeutic measure used to slow the progression of CKD. The putative mechanisms of action responsible for its therapeutic effects include beneficial hemodynamic effects and the limitation of absorbable protein breakdown products that could lead to the accumulation of uremic waste and consequent various deleterious effects. The practical implementation of protein restriction through dietary intervention has been hindered on multiple levels, including patient nonadherence, lack of health care resources, and concerns related to adverse effects associated with the development of protein-energy wasting (PEW). As a result, alternative interventions have been designed to address some or all of these shortcomings and concerns. One such intervention is the administration of medications that prevent the absorption of protein catabolic products from the gut. This article reviews the various interventions using such a strategy to prevent or slow the progression of CKD, with special focus on recent advances in this field.

Original languageEnglish (US)
Pages (from-to)241-245
Number of pages5
JournalJournal of Renal Nutrition
Volume23
Issue number3
DOIs
StatePublished - May 1 2013

Fingerprint

Chronic Renal Insufficiency
Proteins
Dietary Proteins
Health Resources
Angiotensin Receptor Antagonists
Therapeutic Uses
Patient Compliance
Angiotensin-Converting Enzyme Inhibitors
Hemodynamics
Blood Pressure
Delivery of Health Care
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Traditional and Novel Dietary Interventions for Preventing Progression of Chronic Kidney Disease. / Kovesdy, Csaba.

In: Journal of Renal Nutrition, Vol. 23, No. 3, 01.05.2013, p. 241-245.

Research output: Contribution to journalReview article

@article{b9042bfd78984dd4a72d2c6a1b8f1ae4,
title = "Traditional and Novel Dietary Interventions for Preventing Progression of Chronic Kidney Disease",
abstract = "Treatment of chronic kidney disease (CKD) and its complications remain largely unresolved. Currently used treatments include blood pressure control and the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which can slow down the progression of CKD but are unable to halt or reverse it. Dietary protein restriction represents an additional therapeutic measure used to slow the progression of CKD. The putative mechanisms of action responsible for its therapeutic effects include beneficial hemodynamic effects and the limitation of absorbable protein breakdown products that could lead to the accumulation of uremic waste and consequent various deleterious effects. The practical implementation of protein restriction through dietary intervention has been hindered on multiple levels, including patient nonadherence, lack of health care resources, and concerns related to adverse effects associated with the development of protein-energy wasting (PEW). As a result, alternative interventions have been designed to address some or all of these shortcomings and concerns. One such intervention is the administration of medications that prevent the absorption of protein catabolic products from the gut. This article reviews the various interventions using such a strategy to prevent or slow the progression of CKD, with special focus on recent advances in this field.",
author = "Csaba Kovesdy",
year = "2013",
month = "5",
day = "1",
doi = "10.1053/j.jrn.2013.02.001",
language = "English (US)",
volume = "23",
pages = "241--245",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Traditional and Novel Dietary Interventions for Preventing Progression of Chronic Kidney Disease

AU - Kovesdy, Csaba

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Treatment of chronic kidney disease (CKD) and its complications remain largely unresolved. Currently used treatments include blood pressure control and the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which can slow down the progression of CKD but are unable to halt or reverse it. Dietary protein restriction represents an additional therapeutic measure used to slow the progression of CKD. The putative mechanisms of action responsible for its therapeutic effects include beneficial hemodynamic effects and the limitation of absorbable protein breakdown products that could lead to the accumulation of uremic waste and consequent various deleterious effects. The practical implementation of protein restriction through dietary intervention has been hindered on multiple levels, including patient nonadherence, lack of health care resources, and concerns related to adverse effects associated with the development of protein-energy wasting (PEW). As a result, alternative interventions have been designed to address some or all of these shortcomings and concerns. One such intervention is the administration of medications that prevent the absorption of protein catabolic products from the gut. This article reviews the various interventions using such a strategy to prevent or slow the progression of CKD, with special focus on recent advances in this field.

AB - Treatment of chronic kidney disease (CKD) and its complications remain largely unresolved. Currently used treatments include blood pressure control and the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which can slow down the progression of CKD but are unable to halt or reverse it. Dietary protein restriction represents an additional therapeutic measure used to slow the progression of CKD. The putative mechanisms of action responsible for its therapeutic effects include beneficial hemodynamic effects and the limitation of absorbable protein breakdown products that could lead to the accumulation of uremic waste and consequent various deleterious effects. The practical implementation of protein restriction through dietary intervention has been hindered on multiple levels, including patient nonadherence, lack of health care resources, and concerns related to adverse effects associated with the development of protein-energy wasting (PEW). As a result, alternative interventions have been designed to address some or all of these shortcomings and concerns. One such intervention is the administration of medications that prevent the absorption of protein catabolic products from the gut. This article reviews the various interventions using such a strategy to prevent or slow the progression of CKD, with special focus on recent advances in this field.

UR - http://www.scopus.com/inward/record.url?scp=84876710988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876710988&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2013.02.001

DO - 10.1053/j.jrn.2013.02.001

M3 - Review article

VL - 23

SP - 241

EP - 245

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

IS - 3

ER -